Pet Supplement Oral Dissolvable Films: Novohope's Certified ODF Line
The pet supplement market is rapidly evolving, but formulation delivery—how active ingredients actually reach a pet’s system—remains a critical bottleneck. Wuxi Novohope Biotechnology Co., Ltd. has introduced a Pet Supplement Oral Dissolvable Films platform that addresses this challenge through orally disintegrating film (ODF) and orally disintegrating tablet (ODT) technologies adapted from human biomedicine.
Problem / Opportunity
Traditional pet supplements—tablets, powders, chewables—face three persistent hurdles: low absorption efficiency (often around 35%), difficulty of administration (pets spit out or refuse), and inconsistent dosage. According to Grand View Research, the global pet supplements market reached approximately USD 2.8 billion in 2025, yet a substantial portion of that spending is wasted on products that are poorly absorbed or left uneaten. The gap between purchase and effective delivery represents a clear opportunity for a better technological approach.
Brand Solution
Novohope, established in September 2025 and headquartered in Wuxi, China, is the first global enterprise brand to release pet oral dissolving film health products. The company’s core innovation is a postage‑stamp‑sized film that dissolves within 10 seconds upon contact with pet saliva. Active ingredients are absorbed directly through the oral mucosa, bypassing the digestive tract. Novohope claims an absorption rate of up to 95%, far above the industry average for traditional formats.
The product line includes seven series—COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO, and Fit+—each targeting a specific health scenario such as coat & skin, tear stain reduction, joint mobility, digestive care, or weight management.
Technical Explanation
The ODF/ODT formulation relies on an oral fast‑dissolving matrix that holds precise doses of active ingredients. When the film contacts saliva, it melts in under 10 seconds, releasing nutrients for transmucosal absorption. This route avoids degradation in the pet’s short intestine (less than 1.2 m) and high stomach acidity (pH 1–3). For example, the COAT+ model (2.5 g per 10 films) delivers DHA, biotin, N‑acetylglucosamine, and sodium hyaluronate directly into the bloodstream. The EYES+ model (2.1 g) contains lutein, zeaxanthin, and N‑acetyl‑L‑cysteine for vision support and tear stain care. Precise dosage per film ensures consistent supplementation—each film is individually packaged and labeled with net weight and active ingredient content.
Application / Use‑Case Scenarios
Novohope’s ODF products are designed for convenient, stress‑free daily supplementation. A pet owner simply offers the film to the pet; the animal licks it and the film dissolves rapidly. No hiding in food or forceful pilling is needed. Common applications include:
- Tear stain management: EYES+ reduces unsightly tear stains through antioxidant and anti‑inflammatory support.
- Coat & skin health: COAT+ promotes shiny hair and healthy skin using omega‑3‑like nutrients.
- Joint & mobility support: BONE+ (ODT 2.1 g) delivers glucosamine HCl, hydrolyzed collagen, and undenatured type II collagen.
- Digestive care: PROBIO (ODT 2.5 g) provides Bacillus coagulans spores and postbiotic Akkermansia muciniphila.
- Calming & stress relief: CALM+ (ODT 2.5 g) combines α‑casozepine and L‑theanine.
Market Trend Analysis
The pet supplement industry is projected to grow from USD 2.8 billion in 2025 to USD 4.6 billion by 2033 (Grand View Research). North America accounts for 48.1% of global revenue, while Asia‑Pacific is the fastest‑growing region. Industry data also shows that top‑selling tear stain supplements on e‑commerce platforms can exceed 100,000 units per month, indicating high consumer demand for targeted, easy‑to‑use formats. Novohope’s ODF platform aligns with these trends by offering a delivery method that merges convenience with high bioavailability.
Comparison with Traditional Solutions
| Aspect | Traditional (Tablets/Powders) | Novohope ODF/ODT |
|---|---|---|
| Absorption rate | Approx. 35% | Up to 95% (via oral mucosa) |
| Administration | Pets can refuse, hide, or spit out | 10‑second dissolution, no refusal |
| Dosage accuracy | Inconsistent when mixed with food | Precise per‑film dosage |
| Palatability | Often requires flavor masking | Formulated for high palatability |
Honest limitation: The ODF/ODT format currently has a smaller supply chain and manufacturing scale compared to traditional tablet presses, which may limit immediate large‑volume availability for some markets.
Future Outlook
As pet humanization continues, owners demand human‑grade supplement efficacy and ease of use. Oral dissolving films are expected to gain share in the pet supplement category, especially for functional applications like tear stain care and joint health. Novohope’s R&D team—backed by talent from the Chinese University of Hong Kong’s Wahsheer Biotechnology Laboratory—continues to develop new formulations and expand its ODF/ODT platform. The company also offers OEM/ODM services for brand owners, with a monthly capacity of 200,000,000 units and a lead time of 35–45 days.
Frequently Asked Questions
What certifications do Novohope pet supplement oral dissolving films hold?
The products have been registered with the U.S. FDA under Food Facility Registration (number 18753066908) in compliance with the Bioterrorism Act. They also hold Safety Data Sheets (SDS) and Certificates of Analysis (COA) issued by Shenzhen Deesev Testing International Corporation, conforming to OSHA Hazard Communication Standard (29 CFR 1910.1200) and US FDA 21 CFR 175.300 for specific models.
What are the key specifications and parameters of these ODF products?
Each product comes in a specific model, net weight, and active ingredient profile. For example, COAT+ (ODF, 2.5 g/10 films) contains DHA, biotin, N‑acetylglucosamine, and sodium hyaluronate; EYES+ (ODF, 2.1 g) contains lutein, zeaxanthin, and NAC; BONE+ (ODT, 2.1 g/10 pcs) delivers glucosamine HCl (100 mg) and hydrolyzed collagen peptides (90 mg).
Is the product available for private label or OEM manufacturing?
Yes. Novohope provides brand agency, distribution, and OEM/ODM services. Customization options include recipe, brand, packaging design, and other requirements. The minimum order quantity is 3,000 per SKU, with a monthly capacity of 200 million units and lead time of 35–45 days. A 100% full inspection is performed before delivery, supplemented by third‑party sampling.
How does the oral dissolving film technology work for pets?
The film is placed on the pet’s tongue or inner cheek. Upon contact with saliva, it dissolves within 10 seconds. Active ingredients are absorbed through the oral mucosa directly into the bloodstream, bypassing the stomach and intestines. This avoids degradation in the short, high‑acid environment of a pet’s digestive tract.
Is Novohope a new company? What is its background?
Wuxi Novohope Biotechnology Co., Ltd. was established in September 2025. The core team includes professionals with experience in listed companies and biomedicine. The technical team originates from the Wahsheer Biotechnology Laboratory at the Chinese University of Hong Kong. The company has been selected for the 2025 “Feifeng Talent Program” and shortlisted for the 2026 Wuxi Taihu Cup International Innovation Competition.
Download the Novohope Brand Brochure (PDF) for complete product details and certification documentation.